Tolerability of Tuberculosis Chemotherapy in Children

Tolerability of Tuberculosis Chemotherapy in Children

The article presents the review of 61 publications. The topic is highly relevant due to the fact that clinical trials of drugs and chemotherapy regimens usually enroll adults, while children participate only in a small number of them. Often in clinical practice, anti-tuberculosis drugs are prescribe...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. E. Lozovskaya, I. Yu. Motov, G. A. Novik
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2023-12-01
Series:	Туберкулез и болезни лёгких
Subjects:	children tuberculosis multiple drug resistance chemotherapy anti-tuberculosis drugs adverse reactions
Online Access:	https://www.tibl-journal.com/jour/article/view/1771
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

Specific features of the clinical course and chemotherapy of tuberculosis in children exposed to tuberculosis with different drug resistance patterns
by: M. E. Lozovskaya, et al.
Published: (2019-10-01)

Changes of approaches to chemotherapy in children of the tender age over 30-year period
by: A. R. Аroyan, et al.
Published: (2018-11-01)

INDIVIDUAL APPROACHES TO THE CHOICE OF CHEMOTHERAPY REGIMENS FOR RESPIRATORY TUBERCULOSIS IN CHILDREN EXPOSED TO MULTIPLE DRUG RESISTANT TUBERCULOUS INFECTION
by: M. F. Gubkina, et al.
Published: (2016-09-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

Approaches to Selection of Optimal Chemotherapy Regimens in Tuberculosis Patients with Concurrent Diabetes Mellitus
by: O. G. Komissarova, et al.
Published: (2023-12-01)

EFFICACY OF PATIENT-ORIENTED CHEMOTHERAPY OF LOCAL TUBERCULOUS LESIONS IN THE CHILDREN EXPOSED TO MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2019-03-01)

Short course chemotherapy in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkina, et al.
Published: (2020-12-01)

THE NIDUS OF TUBERCULOUS INFECTION AS A RISK FACTOR OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN CHILDREN
by: V. A. Аksenovа, et al.
Published: (2018-01-01)

Risk Factors of Dyspepsia Development during Anti-tuberculosis Chemotherapy in Children
by: E. O. Bryukhacheva, et al.
Published: (2022-10-01)

Efficacy and safety of chemotherapy regimens with bedaquiline in patients with respiratory tuberculosis: immediate and final results
by: S. E. Borisov, et al.
Published: (2019-05-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

FREQUENCY AND CHARACTERISTICS OF ADVERSE REACTIONS TO SECOND LINE ANTI-TUBERCULOSIS DRUGS IN THOSE ILL WITH MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. A. Toktogonova
Published: (2017-11-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Tuberculosis treatment outcomes in children
by: V. A. Аksenova, et al.
Published: (2021-11-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host
by: G. N. Mozhokina, et al.
Published: (2022-09-01)

Investigation of the thiol-disulfide system state of rats with encephalopathy caused by the effect of antituberculous drugs
by: A. V. Levich, et al.
Published: (2019-12-01)

Use of Dispersible Fixed-Dose Combinations in Chemotherapy of Drug Susceptible Tuberculosis: Results of the Observational Study
by: E. S. Nikitina, et al.
Published: (2024-10-01)

Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)

The short-course chemotherapy in the treatment of multiple drug resistant tuberculosis in children with different HIV status
by: E. Yu. Zorkaltseva, et al.
Published: (2019-09-01)

Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
by: R. Yu. Аbdullаev, et al.
Published: (2019-08-01)

A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01)

Clinical and radiological profile of tuberculosis and treatment outcome in patients ≤18 years: A prospective study
by: Kolla Madhuri, et al.
Published: (2025-05-01)

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents
by: V. A. Aksenova, et al.
Published: (2023-12-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)

The Adverse Effects of Tuberculosis Treatment: A Comprehensive Literature Review
by: Rūta Mereškevičienė, et al.
Published: (2025-05-01)

Variety of Adverse Reactions in Rats after Administration of Combination of Anti-tuberculosis and Antimicrobial Drugs with Different Safety Profiles
by: G. N. Mozhokina, et al.
Published: (2022-11-01)

Differentiated Approaches to the Choice of Timing of Surgical Treatment for Intrathoracic Lymph Node Tuberculosis in Children during Increasing Incidence of Multiple Drug Resistant Tuberculosis
by: M. F. Gubkina, et al.
Published: (2022-08-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

Experience of Using Bedaquiline in a Young Child with Drug Resistant Tuberculosis and Concurrent Primary Immunodeficiency
by: T. I. Danilova, et al.
Published: (2021-09-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Delamanid: Safety and Efficacy Analysis
by: G. N. Mozhokina, et al.
Published: (2023-12-01)

Adverse Drug Reactions and Associated Socio-demographic Factors amongst Drug-resistant Tuberculosis Patients: A Retrospective Review
by: Rajesh Tiwari, et al.
Published: (2025-01-01)

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. G. Samoylova, et al.
Published: (2016-09-01)

Assessment of effectiveness of the empiric treatment regimen in tuberculosis patients suspected with multiple drug resistance in the Russian Federation
by: Sergey A. Sterlikov, et al.
Published: (2018-11-01)